These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 9632315)
1. Influence of serotoninergic drugs on in vivo dopamine extracellular output in rat striatum. Santiago M; Matarredona ER; Machado A; Cano J J Neurosci Res; 1998 Jun; 52(5):591-8. PubMed ID: 9632315 [TBL] [Abstract][Full Text] [Related]
2. 5-HT3 receptor agonist induced carrier-mediated release of dopamine in rat striatum in vivo. Santiago M; Machado A; Cano J Br J Pharmacol; 1995 Sep; 116(1):1545-50. PubMed ID: 8564217 [TBL] [Abstract][Full Text] [Related]
3. The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum. Nomikos GG; Arborelius L; Höök BB; Hacksell U; Svensson TH J Neural Transm (Vienna); 1996; 103(5):541-54. PubMed ID: 8811500 [TBL] [Abstract][Full Text] [Related]
4. d-fenfluramine increases striatal extracellular dopamine in vivo independently of serotonergic terminals or dopamine uptake sites. De Deurwaerdère P; Bonhomme N; Le Moal M; Spampinato U J Neurochem; 1995 Sep; 65(3):1100-8. PubMed ID: 7543929 [TBL] [Abstract][Full Text] [Related]
5. Evidence for 5-HT4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane-anesthetized rat. Bonhomme N; De Deurwaèrdere P; Le Moal M; Spampinato U Neuropharmacology; 1995 Mar; 34(3):269-79. PubMed ID: 7543190 [TBL] [Abstract][Full Text] [Related]
6. 8-OH-DPAT influences extracellular levels of serotonin and dopamine in the medial preoptic area of male rats. Lorrain DS; Matuszewich L; Hull EM Brain Res; 1998 Apr; 790(1-2):217-23. PubMed ID: 9593901 [TBL] [Abstract][Full Text] [Related]
7. Possible in vivo 5-HT reuptake blocking properties of 8-OH-DPAT assessed by measuring hippocampal extracellular 5-HT using microdialysis in rats. Assié MB; Koek W Br J Pharmacol; 1996 Nov; 119(5):845-50. PubMed ID: 8922730 [TBL] [Abstract][Full Text] [Related]
8. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone. Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724 [TBL] [Abstract][Full Text] [Related]
9. Activation of 5-HT(1A) but not 5-HT(1B) receptors attenuates an increase in extracellular dopamine derived from exogenously administered L-DOPA in the striatum with nigrostriatal denervation. Kannari K; Yamato H; Shen H; Tomiyama M; Suda T; Matsunaga M J Neurochem; 2001 Mar; 76(5):1346-53. PubMed ID: 11238719 [TBL] [Abstract][Full Text] [Related]
10. Effects of the serotonin1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin on neurochemical responses to stress. Saphier D; Welch JE J Neurochem; 1995 Feb; 64(2):767-76. PubMed ID: 7530293 [TBL] [Abstract][Full Text] [Related]
11. In vivo effects of the putative cognitive enhancer KA-672.HCl in comparison with 8-hydroxy-2-(di-N-propylamino) tetralin and haloperidol on dopamine, 3,4-dihydroxyphenylacetic acid, serotonin and 5-hydroxyindoleacetic acid levels in striatal and cortical brain regions. Teismann P; Ferger B Prog Neuropsychopharmacol Biol Psychiatry; 2000 Feb; 24(2):337-48. PubMed ID: 10800755 [TBL] [Abstract][Full Text] [Related]
12. Serotonin stimulation of 5-HT4 receptors indirectly enhances in vivo dopamine release in the rat striatum. De Deurwaerdère P; L'hirondel M; Bonhomme N; Lucas G; Cheramy A; Spampinato U J Neurochem; 1997 Jan; 68(1):195-203. PubMed ID: 8978726 [TBL] [Abstract][Full Text] [Related]
13. The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens. Ichikawa J; Meltzer HY Brain Res; 2000 Mar; 858(2):252-63. PubMed ID: 10708676 [TBL] [Abstract][Full Text] [Related]
14. Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. Benloucif S; Galloway MP Eur J Pharmacol; 1991 Jul; 200(1):1-8. PubMed ID: 1769366 [TBL] [Abstract][Full Text] [Related]
15. Measurement of 5-hydroxytryptamine release in the rat medial vestibular nucleus using in vivo microdialysis. Inoue S; Kita T; Yamanaka T; Ogawa Y; Nakashima T; Hosoi H Neurosci Lett; 2002 May; 323(3):234-8. PubMed ID: 11959427 [TBL] [Abstract][Full Text] [Related]
16. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output. van Amsterdam C; Seyfried CA Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272 [TBL] [Abstract][Full Text] [Related]
17. 5-HT4 receptor involvement in the serotonin-enhanced dopamine efflux from the substantia nigra of the freely moving rat: a microdialysis study. Thorré K; Ebinger G; Michotte Y Brain Res; 1998 Jun; 796(1-2):117-24. PubMed ID: 9689461 [TBL] [Abstract][Full Text] [Related]
18. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors. Gobert A; Millan MJ Neuropsychopharmacology; 1999 Aug; 21(2):268-84. PubMed ID: 10432475 [TBL] [Abstract][Full Text] [Related]
19. Functional regulation by dopamine receptors of serotonin release from the rat hippocampus: in vivo microdialysis study. Matsumoto M; Yoshioka M; Togashi H; Ikeda T; Saito H Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):621-9. PubMed ID: 8738295 [TBL] [Abstract][Full Text] [Related]
20. Dopaminergic regulation of the serotonergic raphe-striatal pathway: microdialysis studies in freely moving rats. Ferré S; Cortés R; Artigas F J Neurosci; 1994 Aug; 14(8):4839-46. PubMed ID: 7519257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]